Physician
Medagene Clinic , P.A.
Medagene Clinic , P.A. was paid $116K by Medicaid between Jan 2018 and Dec 2024, across 13 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 66% of everything it billed.
33Billing provider infoMEDAGENE CLINIC , P.A.
HOUSTON, TX 77081
HOUSTON, TX 77081
33aNPI1437194685assigned 06/19/2006
33bProvider typeClinical Pathology/Laboratory Medicine Physician
28Total paid$116K
24GClaims3,956
24DCodes billed13
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Pathology/Laboratory Medicine Physician providers in Texas
Rank by total paid#6 of 10
Median peer was paid$116K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13 | $1K | |
| 2020 | 87 | $3K | |
| 2021 | 571 | $17K | |
| 2022 | 1,422 | $40K | |
| 2023 | 1,152 | $34K | |
| 2024incomplete | 711 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 66% | 2,211 | 1,736 | $77K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 607 | 545 | $28K |
| 36410 | 2.5% | 417 | 387 | $3K | |
| 99050 | 1.2% | 95 | 84 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 14 | 14 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 30 | 28 | $1K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 106 | 61 | $1K |
| 99000 | 1.1% | 143 | 127 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 96 | 74 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 39 | 33 | $935.00 |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | <1% | 19 | 19 | $96.00 |
| 97802 | 0% | 147 | 143 | $0.00 |
1 more codes
| 90656 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialURIBEBOTERO, GONZALO (OWNER)